USPTO serial 99659853
Serial No. 99659853
Reviewed by CopyMark Law Group
Status 661
- Filing date
- Status date
- Registration date
- —
- Examiner
- NADEEM, MAHEEN
- Law office
- TMO LAW OFFICE 138
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 99659853?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MAREN COBURN PERRY
MAREN COBURN PERRY KING & SPALDING LLP1290 Avenue of the AmericasNew York, NY 10104United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, and educational course materials in the field of pharmaceutical research and development, disease awareness, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine, medicine, pharmaceuticals, disorders, diseases, clinical or medical treatment and prevention; downloadable computer software for medical and pharmaceutical information, education and sales activities, namely, software featuring audio and video information for pharmaceutical representatives on the subject of pharmaceuticals for use in the treatment of medical conditions; downloadable computer software for analyzing medical and pharmaceutical information and featuring information on disease symptoms for use in promoting disease awareness; downloadable software, namely, application software for mobile devices for analyzing medical and pharmaceutical information; electronic downloadable publications, namely, magazines, journals, and educational course materials in the field of pharmaceutical research and development, science, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine related to clinical or medical treatment and prevention | ACTIVE | — |
| 041 | Educational services, namely, conducting seminars in the field of pharmaceuticals and disease awareness; providing of training in the field of pharmaceuticals and disease awareness; arranging and conducting seminars, conferences, symposiums, training workshops and courses in the field of pharmaceuticals and disease awareness; educational services, namely, training educators in the fields of pharmaceutical research and development, medical clinical tests and trials in the field of pharmaceuticals, diagnostic medicine related to the treatment and prevention of diseases and disorders; providing the aforementioned services, namely, conducting seminars, conferences, symposiums, training workshops and courses, electronically, on-line, via cable or Internet or other electronic media; arranging and conducting on-line training programs in the field of pharmaceuticals; providing on-line, non-downloadable publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, science, medical clinical studies in the field of pharmaceutical tests and trials, diagnostic medicine, pharmaceuticals, disorders, diseases awareness, treatment and prevention related to the assessment of cognitive functions; providing educational assessment services in the field of cognitive functions through on-line non-downloadable screening tools | ACTIVE | — |
| 042 | Pharmaceutical research and development; scientific and technological services, namely, scientific testing and research related to medical disorders, medical diseases and medical prevention; scientific and technological services, namely, scientific testing and research related to the central nervous system and central nervous system related disorders, pharmaceuticals and disease awareness; medical and clinical research, namely, clinical research and conducting clinical trials for others in the field of pharmaceuticals; diagnostic scientific research and tests in the field of pharmaceutical research; providing online non-downloadable screening software for assessing cognitive functions | ACTIVE | — |
| 044 | Medical and clinical healthcare, therapeutic healthcare, healthcare services; providing healthcare information; medical services in the field of psychiatry, psychology, neurology and central nervous system diseases and disorders, namely, healthcare services in the field of psychiatry, psychology and neurology and central nervous system diseases and disorders; providing healthcare information in the field of disease awareness and medical and pharmaceutical preparations and substances related to central nervous system and brain disorders; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing for medical and medicinal information in the field of diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; providing on-line medical record data and analyses services designed to provide patients and clients customized information regarding medical dosage, diagnosis, disease awareness, therapeutic issues and medical management | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 3, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 3, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 3, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 2, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 2, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 2, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2026 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 6, 2026 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 14, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 6, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 6, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 6, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 29, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2026 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 16, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 19, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 19, 2026 | NWAP | NEW APPLICATION ENTERED | — |